1 McFadyen, J. D. et al. C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond. Subcell Biochem 94, 499-520, doi:10.1007/978-3-030-41769-7_20 (2020).
2 Lane, T. et al. Infusion of pharmaceutical-grade natural human C-reactive protein is not proinflammatory in healthy adult human volunteers. Circ Res 114, 672-676, doi:10.1161/CIRCRESAHA.114.302770 (2014).
3 McFadyen, J. D. et al. Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes. Front Immunol 9, 1351, doi:10.3389/fimmu.2018.01351 (2018).
4 Griselli, M. et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 190, 1733-1740 (1999).
5 Pepys, M. B. et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440, 1217-1221 (2006).
6 Gill, R., Kemp, J. A., Sabin, C. & Pepys, M. B. Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats. J Cereb Blood Flow Metab 24, 1214-1218, doi:00004647-200411000-00003 [pii] (2004).
7 Padilla, N. D. et al. C-reactive protein and natural IgM antibodies are activators of complement in a rat model of intestinal ischemia and reperfusion. Surgery 142, 722-733, doi:S0039-6060(07)00356-X [pii]
10.1016/j.surg.2007.05.015 (2007).
8 Thiele, J. R. et al. A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury. Front Immunol 9, 675, doi:10.3389/fimmu.2018.00675 (2018).
9 Eisenhardt, S. U. et al. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res 105, 128-137, doi:10.1161/CIRCRESAHA.108.190611 (2009).
10 Braig, D. et al. A conformational change of C-reactive protein in burn wounds unmasks its proinflammatory properties. Int Immunol, doi:10.1093/intimm/dxu056 (2014).
11 Thiele, J. R. et al. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy. Circulation 130, 35-50, doi:10.1161/CIRCULATIONAHA.113.007124 (2014).
12 Molins, B., Pena, E., de la Torre, R. & Badimon, L. Monomeric CRP is prothrombotic and dissociates from circulating pentameric CRP on adhered activated platelets under flow. Cardiovasc Res, doi:cvr226 [pii] 10.1093/cvr/cvr226 (2011).
13 Braig, D. et al. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites. Nature communications 8, 14188, doi:10.1038/ncomms14188 (2017).
14 Khreiss, T., Jozsef, L., Potempa, L. A. & Filep, J. G. Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res 97, 690-697 (2005).
15 Khreiss, T., Jozsef, L., Potempa, L. A. & Filep, J. G. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 109, 2016-2022 (2004).
16 Zouki, C., Haas, B., Chan, J. S., Potempa, L. A. & Filep, J. G. Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil-endothelial cell adhesion. J Immunol 167, 5355-5361 (2001).
17 Khreiss, T. et al. Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem 277, 40775-40781 (2002).
18 Tegler, L. T. et al. Powerful protein binders from designed polypeptides and small organic molecules--a general concept for protein recognition. Angew Chem Int Ed Engl 50, 1823-1827, doi:10.1002/anie.201005059 (2011).
19 Kumaresan, P. R. et al. Synthesis and characterization of a novel inhibitor of C-reactive protein-mediated proinflammatory effects. Metab Syndr Relat Disord 11, 177-184, doi:10.1089/met.2012.0123 (2013).
20 Warren, M. & Flaim, J. D. Modulation of Inflammatory Responses by C-reactive Protein International Patent WO 2104160211 (2014).
21 Warren, M. S., Hughes, S. G., Singleton, W., Yamashita, M. & Genovese, M. C. Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis. Arthritis Res Ther 17, 80, doi:10.1186/s13075-015-0578-5 (2015).
22 Ries, W., Heigl, F., Garlichs, C., Sheriff, A. & Torzewski, J. Selective C-Reactive Protein-Apheresis in Patients. Ther Apher Dial 23, 570-574, doi:10.1111/1744-9987.12804 (2019).
23 Christopeit, T., Gossas, T. & Danielson, U. H. Characterization of Ca2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor. Anal Biochem 391, 39-44, doi:10.1016/j.ab.2009.04.037 (2009).
24 Thompson, D., Pepys, M. B. & Wood, S. P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7, 169-177 (1999).
25 Diehl, P. et al. Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability. Thromb Haemost 119, 1295-1310, doi:10.1055/s-0039-1683409 (2019).
26 Eisenhardt, S. U., Habersberger, J. & Peter, K. Monomeric C-reactive protein generation on activated platelets: the missing link between inflammation and atherothrombotic risk. Trends Cardiovasc Med 19, 232-237, doi:10.1016/j.tcm.2010.02.002
S1050-1738(10)00004-6 [pii] (2009).
27 Habersberger, J. et al. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. Cardiovasc Res 96, 64-72, doi:10.1093/cvr/cvs237
cvs237 [pii] (2012).
28 Rothlein, R., Dustin, M. L., Marlin, S. D. & Springer, T. A. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 137, 1270-1274 (1986).
29 Yang, L. et al. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood 106, 584-592, doi:10.1182/blood-2004-12-4942 (2005).
30 Eisenhardt, S. U. et al. Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 109, 3521-3528, doi:blood-2006-03-007179 [pii]
10.1182/blood-2006-03-007179 (2007).
31 Cahilog, Z. et al. The Role of Neutrophil NETosis in Organ Injury: Novel Inflammatory Cell Death Mechanisms. Inflammation 43, 2021-2032, doi:10.1007/s10753-020-01294-x (2020).
32 Dashkevich, A. et al. Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts. Am J Transplant 16, 1160-1172, doi:10.1111/ajt.13564 (2016).
33 Nieuwenhuijs-Moeke, G. J. et al. Ischemia and Reperfusion Injury in Kidney Transplantation: Relevant Mechanisms in Injury and Repair. J Clin Med 9, doi:10.3390/jcm9010253 (2020).
34 Mold, C., Gresham, H. D. & Du Clos, T. W. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs. J Immunol 166, 1200-1205 (2001).
35 Biro, A. et al. Studies on the interactions between C-reactive protein and complement proteins. Immunology 121, 40-50, doi:IMM2535 [pii]
10.1111/j.1365-2567.2007.02535.x (2007).
36 Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallographica Section D Biolgical Crystallography 66, 133-144, doi:10.1107/S0907444909047374 (2010).
37 McCoy, A. J. et al. Phaser crystallographic software. J Appl Crystallogr 40, 658-674, doi:10.1107/S0021889807021206 (2007).
38 Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213-221, doi:10.1107/S0907444909052925 (2010).
39 Doi, K. Homotransplantation of limbs in rats. A preliminary report on an experimental study with nonspecific immunosuppressive drugs. Plastic and reconstructive surgery 64, 613-621 (1979).
40 Chang, M. K., Binder, C. J., Torzewski, M. & Witztum, J. L. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A 99, 13043-13048 (2002).
41 Gershov, D., Kim, S., Brot, N. & Elkon, K. B. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192, 1353-1364, doi:10.1084/jem.192.9.1353 (2000).
42 Agrawal, A., Suresh, M. V., Singh, S. K. & Ferguson, D. A., Jr. The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection. Endocr Metab Immune Disord Drug Targets 8, 231-237, doi:10.2174/187153008786848321 (2008).
43 Simons, J. P. et al. C-reactive protein is essential for innate resistance to pneumococcal infection. Immunology 142, 414-420, doi:10.1111/imm.12266 (2014).
44 Mukerji, R. et al. Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine. J Immunol 189, 5327-5335, doi:10.4049/jimmunol.1201967 (2012).
45 McLean, A. G. et al. Patterns of graft infiltration and cytokine gene expression during the first 10 days of kidney transplantation. Transplantation 63, 374-380 (1997).
46 Raftery, M. J. et al. The relevance of induced class II HLA antigens and macrophage infiltration in early renal allograft biopsies. Transplantation 48, 238-243 (1989).
47 Matas, A. J., Gillingham, K. J., Payne, W. D. & Najarian, J. S. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 57, 857-859 (1994).
48 Radu, C. A. et al. Mitomycin-C-treated peripheral blood mononuclear cells (PBMCs) prolong allograft survival in composite tissue allotransplantation. J Surg Res 176, e95-e101, doi:10.1016/j.jss.2011.12.032 (2012).
49 de Beer, F. C. et al. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology 45, 55-70 (1982).
50 Reifenberg, K. et al. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? Arterioscler Thromb Vasc Biol 25, 1641-1646 (2005).
51 Kiefer, J. et al. An Unbiased Flow Cytometry-Based Approach to Assess Subset-Specific Circulating Monocyte Activation and Cytokine Profile in Whole Blood. Front Immunol 12, 641224, doi:10.3389/fimmu.2021.641224 (2021).
52 Megyesi, J., Andrade, L., Vieira, J. M., Jr., Safirstein, R. L. & Price, P. M. Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int 60, 2164-2172, doi:10.1046/j.1523-1755.2001.00044.x (2001).
53 Megyesi, J., Safirstein, R. L. & Price, P. M. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101, 777-782, doi:10.1172/JCI1497 (1998).